Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000175039 | SCV000226465 | benign | not specified | 2015-04-06 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000175039 | SCV000309238 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000344617 | SCV000386919 | benign | Glycogen storage disease, type VI | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000175039 | SCV000540142 | benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in ESP (all): 5552/12518=44.35% |
Invitae | RCV000344617 | SCV001724557 | benign | Glycogen storage disease, type VI | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000344617 | SCV002033358 | benign | Glycogen storage disease, type VI | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000675364 | SCV000801030 | benign | not provided | 2015-10-23 | no assertion criteria provided | clinical testing |